AstraZeneca to Acquire Amolyt Pharma in Deal Worth Potentially $1.05 Billion - Global Search, Local Care | The Future of Medical Consultation


ChatMedical.AI, an innovator in AI healthcare, is a key subsidiary of UL Cell Therapeutic, a leading medical research firm based in Singapore with significant operations in North America and Asia